Barclays PLC Becton Dickinson & CO Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Barclays PLC holds 512,401 shares of BDX stock, worth $115 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
512,401
Previous 662,293
22.63%
Holding current value
$115 Million
Previous $160 Million
27.2%
% of portfolio
0.03%
Previous 0.04%
Shares
30 transactions
Others Institutions Holding BDX
# of Institutions
1,803Shares Held
260MCall Options Held
1.27MPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA26.7MShares$5.99 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$4.99 Billion0.12% of portfolio
-
State Street Corp Boston, MA14.1MShares$3.16 Billion0.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$2.77 Billion0.32% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.1MShares$2.72 Billion1.7% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $63.9B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...